Abstract
Rationale
Single-dose administration of selective serotonin and noradrenaline reuptake blockers has been shown to alter emotional processing in both behavioral and fMRI studies in healthy volunteers. Mirtazapine is a clinically established antidepressant with different pharmacological actions from monoamine reuptake inhibitors, involving blockade of noradrenaline α2-adrenoceptors and multiple 5-HT receptor subtypes. The aim of this study was to investigate the effect of a single dose of mirtazapine on the neural processing of emotional faces in healthy volunteers.
Methods
Twenty-eight participants were randomized to receive either a single dose of mirtazapine (15 mg) or placebo. Two hours later, participants underwent an fMRI scan, in which they classified fearful and happy faces on the basis of gender. Mood and subjective experience were also measured.
Results
Whole-brain analysis showed significant group × emotion interactions in a right amygdala-hippocamal region and left fronto-striatal cortex. Post hoc analyses revealed significantly reduced activation to fear and greater activation to happy faces in both regions under mirtazapine.
Conclusions
Our findings indicate that a single dose of mirtazapine modulates neural activity to affective stimuli. Mirtazapine was found to decrease neural responses to fear and increase responses to happy facial expressions in regions implicated in the processing of emotional faces. These effects may be important for our understanding of the neural mechanisms of antidepressant action in anxiety and depression.
Similar content being viewed by others
References
Arnone D, Horder J, Cowen PJ, Harmer CJ (2009) Early effects of mirtazapine on emotional processing. Psychopharmacology 203:685–691. doi:10.1007/s00213-008-1410-6
Beck AT, Erbaugh J, Ward CH, Mock J, Mendelsohn M (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561
Beckmann CF, Smith SM (2004) Probabilistic independent componenet analysis for functional magnetic resonance imaging. IEEE Trans Med Imag 23(2):137–152
Bigos KL, Pollock BG, Aizenstein HJ, Fischer PM, Bies RR, Hariri AH (2008) Acute 5-HT reuptake blockade potentiates human amygdala reactivity. Neuropsychopharmacology 33:3221–3225
Bond AJ, Lader MH (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol: 211–218
Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C (2009) Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 373:746–758. doi:10.1016/S0140-6736(09)60046-5
Davidson RJ, Irwin W, Anderle MJ, Kalin NH (2003) The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry 160:64–75
Davis R, Wilde MI (1996) Mirtazapine—A review of its pharmacology and therapeutic potential in the management of major depression. Cns Drugs 5:389
Del-Ben CM, Deakin JF, McKie S, Delvai NA, Williams SR, Elliott R, Dolan M, Anderson IM (2005) The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study. Neuropsychopharmacology 30:1724–1734. doi:10.1038/sj.npp.1300728
Eysenck HJ, Eysenck MW (1985) Personality and individual differences: a natural science approach. Plenum, New York
First MB, Spitzer RL, Gibbon M, Williams JBW (1997) Structured clinical interview for DSM-IV axis I disorders—clinician version (SCID-CV). American Psychiatric, Washington DC
Friston KJ, Worsley KJ, Frackowiak RS, Mazziotti JC, Evans AC (1994) Assessing the significance of focal activations using their spatial extent. Hum Brain Mapp 1:210–220
Fu CH, Williams SC, Cleare AJ, Brammer MJ, Walsh ND, Kim J, Andrew CM, Pich EM, Williams PM, Reed LJ, Mitterschiffthaler MT, Suckling J, Bullmore ET (2004) Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry 61:877–889. doi:10.1001/archpsyc.61.9.877
Fu CH, Williams SC, Cleare AJ, Scott J, Mitterschiffthaler MT, Walsh ND, Donaldson C, Suckling J, Andrew C, Steiner H, Murray RM (2008) Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biol Psychiatry 64:505–512. doi:10.1016/j.biopsych.2008.04.033
Harmer CJ, Bhagwagar Z, Perrett DI, Vollm BA, Cowen PJ, Goodwin GM (2003a) Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology 28:148–152
Harmer CJ, Hill SA, Taylor MJ, Cowen PJ, Goodwin GM (2003b) Toward a neuropsychological theory of antidepressant drug action: increase in positive emotional bias after potentiation of norepinephrine activity. Am J Psychiatry 160:990–992
Harmer CJ, Shelley NC, Cowen PJ, Goodwin GM (2004) Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry 161:1256–1263
Harmer CJ, Mackay CE, Reid CB, Cowen PJ, Goodwin GM (2006) Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry 59:816–820. doi:10.1016/j.biopsych.2005.10.015
Harmer CJ, Heinzen J, O’Sullivan U, Ayres RA, Cowen PJ (2008) Dissociable effects of acute antidepressant drug administration on subjective and emotional processing measures in healthy volunteers. Psychopharmacology (Berl) 199:495–502
Harmer CJ, O’Sullivan U, Favaron E, Massey-Chase R, Ayres R, Reinecke A, Goodwin CM, Cowen PJ (2009) Effect of acute antidepressant administration on negative affective bias in depressed patients. Am J Psychiatry 166:1178–1184
Jenkinson M (2003) Fast, automated, N-dimensional phase-unwrapping algorithm. MRM 49:193–197
Jenkinson M, Smith S (2001) A global optimisation method for robust affine registration of brain images. Med Image Anal 5:143–156
Jenkinson M, Bannister P, Brady M, Smith S (2002) Improved optimisation for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17:825–841
Jenkinson M, Wilson J, Jezzard P (2004) A peturbation for magnetic field calculations of non-conductive objects. MRM 52:471–477
Kent JM, Coplan JD, Gorman JM (1998) Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety. Biol Psychiatry 44:812–824
Lader MH, Scotto JC (1998) A multicentre double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder. Psychopharmacology 139:402–406
Millan MJ, Gobert A, Lejeune F, Dekeyne A, Newman-Tancredi A, Pasteau V, Rivet JM, Cussac D (2003) The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharmacol Exp Ther 306:954–964. doi:10.1124/jpet.103.051797
Morris JS, Frith CD, Perrett DI, Rowland D, Young AW, Calder AJ, Dolan RJ (1996) A differential neural response in the human amygdala to fearful and happy facial expressions. Nature 383:812–815. doi:10.1038/383812a0
Murphy SE, Norbury R, O’Sullivan U, Cowen PJ, Harmer CJ (2009) Effect of a single dose of citalopram on amygdala response to emotional faces. Br J Psychiatry 194:535–540. doi:10.1192/bjp.bp.108.056093
Nelson HE, Willison JR (1991) The revised national adult reading test—test manual. NFER, Windsor
Norbury R, Mackay CE, Cowen PJ, Goodwin GM, Harmer CJ (2007) Short-term antidepressant treatment and facial processing. Functional magnetic resonance imaging study. Br J Psychiatry 190:531–532. doi:10.1192/bjp.bp.106.031393
Norbury R, Selvaraj S, Taylor MJ, Harmer C, Cowen PJ (2009a) Increased neural response to fear in patients recovered from depression: a 3 T functional magnetic resonance imaging study. Psychol Med:1–8. doi:10.1017/S0033291709990596
Norbury R, Taylor MJ, Selvaraj S, Murphy SE, Harmer CJ, Cowen PJ (2009b) Short-term antidepressant treatment modulates amygdala response to happy faces. Psychopharmacology (Berl) 206:197–204. doi:10.1007/s00213-009-1597-1
Olivier B, Van Wijngaarden I, Soudijn W (2000) 5-HT3 receptor antagonists and anxiety; a preclinical and clinical review. Eur Neuropsychopharmacol 10:77–95
Phillips ML, Drevets WC, Rauch SL, Lane R (2003a) Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biol Psychiatry 54:515–528
Phillips ML, Drevets WC, Rauch SL, Lane R (2003b) Neurobiology of emotion perception I: the neural basis of normal emotion perception. Biol Psychiatry 54:504–514
Rolls ET (1999) The brain and emotion. Oxford Univ. Press, Oxford, UK
Sheline YI, Barch DM, Donnelly JM, Ollinger JM, Snyder AZ, Mintun MA (2001) Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry 50:651–658
Siegle GJ, Thompson W, Carter CS, Steinhauer SR, Thase ME (2007) Increased amygdala and decreased dorsolateral prefrontal BOLD response in unipolar depression: related and independent features. Biol Psychiatry 61:198–209
Smith S (2002) Fast robust automated brain extraction. Hum Brain Mapp 17:143–155
Smith S, Jenkinson M, Woolrich MW, Beckman CF, Behrens TEJ, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney D, Niazy N, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady M, Matthews PM (2004) Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23:S208–S219
Speielberger C, Gorsuch A, Lushene R (1970) State-trait anxiety inventory. Consulting Psychologists, Palo Alto
Surguladze SA, Brammer MJ, Young AW, Andrew C, Travis MJ, Williams SC, Phillips ML (2003) A preferential increase in the extrastriate response to signals of danger. Neuroimage 19:1317–1328
Timmer CJ, Sitsen JM, Delbressine LP (2000) Clinical pharmacokinetics of mirtazapine. Clin Pharmacokinet 38:461–474
Tranter R, Bell D, Gutting P, Harmer C, Healy D, Anderson IM (2009) The effect of serotonergic and noradrenergic antidepressants on face emotion processing in depressed patients. J Affect Disord 118:87–93
Tse WS, Bond AJ (2003) Reboxetine promotes social bonding in healthy volunteers. J Psychopharmacol 17:189–195
Von Zerssen D (1986) Clinical Self Rating Scales (CSRS) of the Munich Psychiatric Information System (PSYCHIS Munchen). In: Sartorius N B, T (ed) Assessment of depression. Springer, Berlin, Heidelberg, New York, Tokyo, pp 270–303
Vuilleumier P (2005) How brains beware: neural mechanisms of emotional attention. Trends Cogn Sci 9:585–594
Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, McGuire H, Churchill R, Furukawa TA, Multiple Meta-Analyses of New Generation Antidepressants (MANGA) Study Group (2008) Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis. J Clin Psychiatry 69:1404–1415
Williams LM, Phillips ML, Brammer MJ, Skerrett D, Lagopoulos J, Rennie C, Bahramali H, Olivieri G, David AS, Peduto A, Gordon E (2001) Arousal dissociates amygdala and hippocampal fear responses: evidence from simultaneous fMRI and skin conductance recording. Neuroimage 14:1070–1079. doi:10.1006/nimg.2001.0904
Woolrich MW, Ripley BD, Brady M, Smith SM (2001) Temporal autocorrelation in univariate linear modeling of FMRI data. Neuroimage 14:1370–1386. doi:10.1006/nimg.2001.0931
Woolrich MW, Behrens TE, Beckmann CF, Jenkinson M, Smith SM (2004) Multilevel linear modelling for FMRI group analysis using Bayesian inference. Neuroimage 21:1732–1747. doi:10.1016/j.neuroimage.2003.12.023
Acknowledgement
Thanks to Martina Di Simplicio, Michael Browning, and Sarah McTavish.
Conflict of interest
CJH is on the advisory board for P1vital and holds shares in the company. She has also received consultancy fees from GlaxoSmithKline, Servier, P1vital, Lundbeck, and AstraZeneca. PJC has been a paid member of advisory boards of DSM, Eli Lilly, Servier, Wyeth, and Xytis and has been a paid lecturer for Eli Lilly, Servier, and GlaxoSmithKline. He has received remuneration for scientific advice given to legal representatives of GlaxoSmithKline.
Author information
Authors and Affiliations
Corresponding author
Additional information
* Development of the MacBrain Face Stimulus Set was overseen by Nim Tottenham and supported by the John D. and Catherine T. MacArthur Foundation Research Network on Early Experience and Brain Development. Please contact Nim Tottenham at tott0006@tc.umn.edu for more information concerning the stimulus set.
This study was supported by the MRC.
Rights and permissions
About this article
Cite this article
Rawlings, N.B., Norbury, R., Cowen, P.J. et al. A single dose of mirtazapine modulates neural responses to emotional faces in healthy people. Psychopharmacology 212, 625–634 (2010). https://doi.org/10.1007/s00213-010-1983-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-010-1983-8